We are live on ! Find out more
GCM

Glenview Capital Management Portfolio holdings

AUM $5.49B
1-Year Est. Return 46.89%
This Fund
S&P 500
This Quarter Est. Return
+2.48%
1 Year Est. Return
+46.89%
3 Year Est. Return
+94.27%
5 Year Est. Return
+129.04%
10 Year Est. Return
+529.98%
AUM
$14.8B
AUM Growth
+$810M
Cap. Flow
+$541M
Cap. Flow %
3.66%
Top 10 Hldgs %
51.83%
Holding
58
New
8
Increased
21
Reduced
12
Closed
9
Avg Time Held Equity + Options
6.2 quarters
Top 10 Avg Time Held Equity + Options
4.5 quarters
Top 20 Avg Time Held Equity + Options
6.2 quarters
Avg Time Held Equity only
6.4 quarters
Top 10 Avg Time Held Equity only
4.5 quarters
Top 20 Avg Time Held Equity only
6.2 quarters

Top Buys

Rank Stock Value
1
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$313M
2
LOW icon
Lowe's Companies
LOW
+$288M
3
AAPL icon
Apple
AAPL
+$281M
4
IQV icon
IQVIA
IQV
+$272M
5
ABBV icon
AbbVie
ABBV
+$188M

Top Sells

Rank Stock Value
1
HUM icon
Humana
HUM
+$613M
2
PARA icon
Paramount Global Class B
PARA
+$497M
3
IMS
IMS HEALTH HLDGS INC COM STK (DE)
IMS
+$233M
4
DD icon
Du Pont De Nemours E I
DD
+$122M
5
TEVA icon
Teva Pharmaceutical Industries Limited
TEVA
+$100M

Sector Composition

Rank Sector Weight
1 Healthcare 51.72%
2 Communication Services 10.85%
3 Technology 9.92%
4 Materials 8.65%
5 Financials 5.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
HCA icon
1
HCA Healthcare
HCA
$101B
$1.35B 9.1%
18,181,441
+2,192,451
+14% +$164M
2013 Q2
14 quarters
HUM icon
2
Humana
HUM
$51B
$1.29B 8.71%
6,313,790
-3,215,385
-34% -$613M
2013 Q2
14 quarters
ELV icon
3
Elevance Health
ELV
$93.4B
$845M 5.71%
5,874,049
+276,807
+5% +$37.1M
2014 Q1
11 quarters
CI icon
4
Cigna
CI
$75.8B
$755M 5.11%
5,662,086
-329,310
-5% -$43.1M
2013 Q2
14 quarters
AET
5
DELISTED
Aetna Inc
AET
$644M 4.35%
5,194,064
+14,348
+0.3% +$1.72M
2013 Q4
12 quarters
GOOGL icon
6
Alphabet (Google) Class A
GOOGL
$4.35T
$605M 4.09%
15,272,100
+7,835,120
+105% +$313M
2015 Q4
4 quarters
ABBV icon
7
AbbVie
ABBV
$489B
$571M 3.86%
9,116,969
+3,086,828
+51% +$188M
2015 Q1
7 quarters
FMC icon
8
FMC
FMC
$1.29B
$540M 3.65%
11,008,634
-1,000,466
-8% -$45.7M
2015 Q1
7 quarters
LH icon
9
Labcorp
LH
$25.7B
$538M 3.64%
4,875,135
-27,663
-0.6% -$3.07M
2015 Q2
6 quarters
FLEX icon
10
Flex
FLEX
$39.9B
$534M 3.61%
49,325,372
-2,388,600
-5% -$25.5M
2013 Q2
14 quarters
IQV icon
11
IQVIA
IQV
$43B
$527M 3.56%
6,927,335
+3,545,713
+105% +$272M
2016 Q2
2 quarters
TMO icon
12
Thermo Fisher Scientific
TMO
$247B
$516M 3.49%
3,659,734
+973,418
+36% +$144M
2013 Q2
14 quarters
CSC
13
DELISTED
Computer Sciences
CSC
$514M 3.48%
8,655,256
+1,013,409
+13% +$58.6M
2015 Q4
4 quarters
DD icon
14
DuPont de Nemours
DD
$17.5B
$503M 3.4%
3,474,197
+1,143,931
+49% +$159M
2014 Q3
9 quarters
AAPL icon
15
Apple
AAPL
$5.02T
$365M 2.47%
12,612,380
+9,895,528
+364% +$281M
2016 Q3
1 quarter
PARA icon
16
DELISTED
Paramount Global Class B
PARA
$326M 2.21%
5,128,539
-8,371,888
-62% -$497M
2013 Q2
14 quarters
CAR icon
17
Avis
CAR
$3.76B
$304M 2.06%
8,298,004
– –
2014 Q1
11 quarters
EHC icon
18
Encompass Health
EHC
$12.3B
$300M 2.03%
9,138,113
+125,700
+1% +$4.08M
2015 Q1
7 quarters
LOW icon
19
Lowe's Companies
LOW
$106B
$290M 1.96%
+4,076,119
New +$288M
2016 Q4
0 quarters
THC icon
20
Tenet Healthcare
THC
$21.6B
$265M 1.79%
17,890,230
– –
2013 Q2
14 quarters
WMB icon
21
Williams Companies
WMB
$90.9B
$263M 1.78%
8,439,958
+1,400
+0% +$42.2K
2016 Q2
2 quarters
LBTYA icon
22
Liberty Global Class A
LBTYA
$2.91B
$239M 1.62%
7,820,359
+3,533,708
+82% +$112M
2014 Q2
10 quarters
CHTR icon
23
Charter Communications
CHTR
$12.1B
$222M 1.5%
772,597
+100,000
+15% +$26.9M
2015 Q3
5 quarters
BKD icon
24
Brookdale Senior Living
BKD
$2.44B
$207M 1.4%
16,630,415
– –
2014 Q2
10 quarters
FDC
25
DELISTED
First Data Corporation
FDC
$192M 1.3%
13,547,383
+2,009,754
+17% +$28.6M
2016 Q2
2 quarters
1
2 3

Similar funds

GCM
Graham Capital Management Rowayton, Connecticut $5.5B AUM 26.66% 1-Year Est. Return
VCM
Voleon Capital Management Berkeley, California $5.49B AUM 56.94% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return
MC
Maplelane Capital New York $5.51B AUM 67.92% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
NC
Nicholas Company Milwaukee, Wisconsin $5.47B AUM 16.96% 1-Year Est. Return
EI
EFG International Zurich $5.46B AUM
AP
Antipodes Partners Royal Exchange, Australia $5.46B AUM 26.64% 1-Year Est. Return

Glenview Capital Management's Q4 2016 Portfolio in Review

As of Q4 2016, Glenview Capital Management held 58 positions worth $14.8B, up 5.8% from $14B the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Glenview Capital Management deployed $541M of net new capital in Q4 2016, opening 8 new positions and adding to 21 existing holdings. Its largest new stake was Lowe's Companies: 4,076,119 shares worth $290M.

By sector, the portfolio is most concentrated in Healthcare at 52% of assets, down from 53% a quarter earlier, followed by Communication Services and Technology.

On the sell side, the largest reduction was Humana, an estimated $613M trimmed.

  • Glenview Capital Management's largest Q4 2016 buy was Lowe's Companies: 4,076,119 shares worth $290M.
  • Glenview Capital Management added most to Alphabet (Google) Class A in Q4 2016, an estimated $313M increase.
  • Glenview Capital Management's biggest Q4 2016 reduction was Humana, cutting an estimated $613M.
  • Glenview Capital Management fully exited IMS HEALTH HLDGS INC COM STK (DE) in Q4 2016, selling an estimated $233M.
  • Glenview Capital Management's ten largest holdings make up 52% of its $14.8B portfolio in Q4 2016.
  • Glenview Capital Management opened 8 new positions and closed 9 in Q4 2016.
  • Glenview Capital Management's portfolio value rose 5.8% quarter-over-quarter to $14.8B.

Based on Glenview Capital Management's 13F filing for Q4 2016, filed 14 Feb 2017.